Medtronic Other, net increased by 125.0% to $70.00M in Q2 2025 compared to the prior quarter. Year-over-year, this metric grew by 566.7%, from -$15.00M to $70.00M. Over 3 years (FY 2021 to FY 2025), Other, net shows an upward trend with a -12.3% CAGR.
Fluctuations are often non-recurring; significant changes should be analyzed via footnotes to determine if they represent structural shifts in financing strategy.
This metric aggregates miscellaneous cash flows related to financing activities that do not fall into primary categories...
Standard line item in cash flow statements; varies significantly by company based on the complexity of their capital structure.
financing_proceeds_from_payments_for_other_financing_activities| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$164.00M | -$4.00M | $447.00M | -$495.00M | $215.00M | $273.00M | -$120.00M | -$429.00M | -$133.00M | -$8.00M | -$56.00M | -$15.00M | $80.00M | $31.00M | -$280.00M | $70.00M |
| QoQ Change | — | +97.6% | >999% | -210.7% | +143.4% | +27.0% | -144.0% | -257.5% | +69.0% | +94.0% | -600.0% | +73.2% | +633.3% | -61.3% | <-999% | +125.0% |
| YoY Change | — | — | — | — | +231.1% | >999% | -126.8% | +13.3% | -161.9% | -102.9% | +53.3% | -87.5% | +242.9% | — | — | +566.7% |